Fondazione Stella Maris

Their core work

Fondazione Stella Maris is a clinical research centre in Pisa, Italy, affiliated with the University of Pisa, specializing in paediatric neurology and neurodevelopmental disorders. They conduct clinical research on conditions such as autism spectrum disorder, cerebral palsy, and intellectual disability, with a strong focus on early detection and diagnosis in infants and children. Their work bridges fundamental neuroscience with clinical application, contributing patient cohorts, clinical expertise, and translational research to large European consortia studying neurodevelopmental conditions.

What they specialise in

How they've shifted over time

Fondazione Stella Maris began its H2020 participation in 2015 with visual neuroscience training (NextGenVis), reflecting a broader neuroscience foundation. From 2018 onward, the centre sharpened its focus toward applied clinical neurodevelopmental research — first autism biomarkers and trials (AIMS-2-TRIALS), then cerebral palsy early detection (BornToGetThere). The trajectory shows a clear shift from fundamental neuroscience toward clinical implementation of early diagnosis and intervention for children with neurodevelopmental conditions.

Moving decisively toward clinical implementation of early detection tools for paediatric neurodevelopmental conditions, making them a strong partner for translational projects bridging diagnosis and intervention.

How they like to work

Fondazione Stella Maris operates exclusively as a consortium participant, contributing clinical expertise and patient access rather than leading project coordination. With 84 unique partners across 18 countries from just 3 projects, they participate in very large multinational consortia — AIMS-2-TRIALS alone is a massive multi-site autism research programme. This profile suggests a trusted clinical site that large consortia seek out for their paediatric neurology patient populations and clinical research infrastructure.

Despite only 3 projects, Fondazione Stella Maris has collaborated with 84 unique partners across 18 countries, reflecting participation in large-scale European clinical research networks. Their geographic reach spans most of Europe, consistent with multi-site clinical trials and training networks.

What sets them apart

Fondazione Stella Maris brings a rare combination: a dedicated paediatric neurology research hospital with direct access to clinical populations of children with autism, cerebral palsy, and intellectual disability. For consortium builders, this means a partner that can contribute real patient data, clinical validation, and implementation testing — not just laboratory research. Their University of Pisa affiliation adds academic rigour while the foundation structure ensures a clinical, patient-facing orientation.

Highlights from their portfolio

• AIMS-2-TRIALS
  One of Europe's largest autism research programmes, focused on identifying biomarkers and improving clinical trial design for autism medicines.
• BornToGetThere
  Directly addresses implementation of early detection services for cerebral palsy in infants — their largest single EU funding (EUR 628K) and most clinically applied project.